Literature DB >> 18458848

High-sensitivity C-reactive protein and metabolic syndrome (insulin resistance syndrome), including nonalcoholic steatohepatitis.

Eiji Oda, Kenichi Watanabe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18458848     DOI: 10.1007/s00535-008-2175-8

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  10 in total

1.  Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans.

Authors:  Saverio Cinti; Grant Mitchell; Giorgio Barbatelli; Incoronata Murano; Enzo Ceresi; Emanuela Faloia; Shupei Wang; Melanie Fortier; Andrew S Greenberg; Martin S Obin
Journal:  J Lipid Res       Date:  2005-09-08       Impact factor: 5.922

2.  Waist circumference and cardiometabolic risk: a consensus statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes Association.

Authors:  Samuel Klein; David B Allison; Steven B Heymsfield; David E Kelley; Rudolph L Leibel; Cathy Nonas; Richard Kahn
Journal:  Am J Clin Nutr       Date:  2007-05       Impact factor: 7.045

3.  C-Reactive protein cutoff-point of 0.65 mg/L may be appropriate not only as a component of metabolic syndrome but also as a risk predictor of cardiovascular disease.

Authors:  Eiji Oda
Journal:  Circ J       Date:  2007-09       Impact factor: 2.993

4.  The optimal cut-off point of C-reactive protein as an optional component of metabolic syndrome in Japan.

Authors:  Eiji Oda; Kazuhiko Oohara; Akihiro Abe; Punniyakoti T Veeraveedu; Kenichi Watanabe; Kiminori Kato; Yoshifusa Aizawa
Journal:  Circ J       Date:  2006-04       Impact factor: 2.993

5.  MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity.

Authors:  Hajime Kanda; Sanshiro Tateya; Yoshikazu Tamori; Ko Kotani; Ken-ichi Hiasa; Riko Kitazawa; Sohei Kitazawa; Hitoshi Miyachi; Sakan Maeda; Kensuke Egashira; Masato Kasuga
Journal:  J Clin Invest       Date:  2006-05-11       Impact factor: 14.808

6.  Obesity-associated improvements in metabolic profile through expansion of adipose tissue.

Authors:  Ja-Young Kim; Esther van de Wall; Mathieu Laplante; Anthony Azzara; Maria E Trujillo; Susanna M Hofmann; Todd Schraw; Jorge L Durand; Hua Li; Guangyu Li; Linda A Jelicks; Mark F Mehler; David Y Hui; Yves Deshaies; Gerald I Shulman; Gary J Schwartz; Philipp E Scherer
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

7.  High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH.

Authors:  Masato Yoneda; Hironori Mawatari; Koji Fujita; Hiroshi Iida; Kyoko Yonemitsu; Shingo Kato; Hirokazu Takahashi; Hiroyuki Kirikoshi; Masahiko Inamori; Yuichi Nozaki; Yasunobu Abe; Kensuke Kubota; Satoru Saito; Tomoyuki Iwasaki; Yasuo Terauchi; Shinji Togo; Shiro Maeyama; Atsushi Nakajima
Journal:  J Gastroenterol       Date:  2007-07-25       Impact factor: 7.527

8.  Considerable disagreement among definitions of metabolic syndrome for Japanese.

Authors:  Eiji Oda; Masahiro Abe; Punniyakoti T Veeraveedu; Kenichi Watanabe
Journal:  Circ J       Date:  2007-08       Impact factor: 2.993

9.  High-sensitivity C-reactive protein is quite low in Japanese men at high coronary risk.

Authors:  Kunihiro Matsushita; Hiroshi Yatsuya; Koji Tamakoshi; Pei Ou Yang; Rei Otsuka; Keiko Wada; Hirotsugu Mitsuhashi; Yo Hotta; Takahisa Kondo; Toyoaki Murohara; Hideaki Toyoshima
Journal:  Circ J       Date:  2007-06       Impact factor: 2.993

10.  Visceral obesity without insulin resistance in late-onset obesity rats.

Authors:  Randip K Bains; Sara E Wells; Dave M Flavell; Keith M Fairhall; Molly Strom; Paul Le Tissier; Iain C A F Robinson
Journal:  Endocrinology       Date:  2004-03-19       Impact factor: 4.736

  10 in total
  1 in total

Review 1.  Nonalcoholic fatty liver disease: Diagnostic biomarkers.

Authors:  Fatemeh Hadizadeh; Elham Faghihimani; Peyman Adibi
Journal:  World J Gastrointest Pathophysiol       Date:  2017-05-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.